Singapore Cancer Network (SCAN) Guidelines for Systemic Therapy of Colorectal Cancer.

INTRODUCTION The SCAN colorectal cancer systemic therapy workgroup aimed to develop Singapore Cancer Network (SCAN) clinical practice guidelines for systemic therapy for colorectal cancer in Singapore. MATERIALS AND METHODS The workgroup utilised a modified ADAPTE process to calibrate high quality international evidence-based clinical practice guidelines to our local setting. RESULTS Five international guidelines were evaluated-those developed by the National Comprehensive Cancer Network for colon (2014) and rectal (2014) cancer, the European Society of Medical Oncology for advanced (2012) and early (2013) cancer and the National Institute of Clinical Excellence (2011). Recommendations on systemic therapy in colorectal cancer were produced. CONCLUSION These adapted guidelines form the SCAN Guidelines 2015 for systemic therapy of colorectal cancer.

• Publication year

  2015

• Venue

  Annals of the Academy of Medicine, Singapore

• Publication date

  2015-10-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.47102/annals-acadmedsg.v44n10p379PMID 26763055
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Final results and subgroup analyses of the phase 3 CAIRO3 study: Maintenance treatment with capecitabine + bevacizumab versus observation after induction treatment with chemotherapy + bevacizumab in metastatic colorectal cancer (mCRC).

  2014cited by this paper
• Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial.

  2014cited by this paper
• Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial

  2014cited by this paper
• The clinical effectiveness and cost-effectiveness of cetuximab (mono- or combination chemotherapy), bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy (review of technology appraisa

  2013cited by this paper
• Cancer trends and incidences in Singapore.

  2013cited by this paper
• Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2013cited by this paper
• Maintenance treatment with capecitabine and bevacizumab versus observation after induction treatment with chemotherapy and bevacizumab in metastatic colorectal cancer (mCRC): The phase III CAIRO3 study of the Dutch Colorectal Cancer Group (DCCG).

  2013cited by this paper
• ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.

  2012cited by this paper
• Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial

  2011cited by this paper
• Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses.

  2011cited by this paper
• Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

  2008cited by this paper
• Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

  2007cited by this paper
• Adaptation of clinical guidelines: literature review and proposition for a framework and procedure.

  2006cited by this paper
• Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

  2004cited by this paper
• Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators.

  1999cited by this paper

• Contrast-enhanced Ultrasonography for Diagnosis of Small Intestinal Leiomyosarcoma with Hepatic Metastasis: A Clinical Report of One Case and Review of the Literature.

  2023cites this paper
• Treatment of Patients With Late-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline

  2020cites this paper
• ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach.

  2019cites this paper
• Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS

  2018cites this paper
• Circulating Tumor Cells and Circulating Tumor DNA in Colorectal Cancer

  2016cites this paper